• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997
• 4. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504
• 5. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

4-Bromo-3-methyl-benzoic Acid Hydrazide (CAS No. 148672-43-9): A Comprehensive Overview

4-Bromo-3-methyl-benzoic Acid Hydrazide (CAS No. 148672-43-9) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, holds potential applications in various therapeutic areas, particularly in the development of novel drugs and chemical probes. In this article, we will delve into the chemical properties, synthesis methods, and recent advancements in the research and application of 4-Bromo-3-methyl-benzoic Acid Hydrazide.

Chemical Structure and Properties

4-Bromo-3-methyl-benzoic Acid Hydrazide is a derivative of benzoic acid with a bromine atom at the 4-position and a methyl group at the 3-position. The hydrazide functional group (-NH-NH2) imparts unique reactivity and biological activity to the molecule. The compound has a molecular formula of C9H10BrN2O2 and a molecular weight of approximately 250.09 g/mol. It is typically a white crystalline solid with a melting point ranging from 150 to 152°C.

The presence of the bromine atom and the hydrazide group in 4-Bromo-3-methyl-benzoic Acid Hydrazide makes it an attractive candidate for various chemical reactions, including coupling reactions, condensations, and derivatizations. These properties are crucial for its use in synthetic chemistry and drug discovery.

Synthesis Methods

The synthesis of 4-Bromo-3-methyl-benzoic Acid Hydrazide can be achieved through several well-established methods. One common approach involves the reaction of 4-bromo-3-methyl-benzoic acid with hydrazine hydrate under mild conditions. This reaction typically proceeds via an acyl chloride intermediate, which is formed by treating the carboxylic acid with thionyl chloride or another suitable reagent.

A typical synthetic route is as follows:

1. Treatment of 4-bromo-3-methyl-benzoic acid with thionyl chloride to form the corresponding acyl chloride.
2. Reaction of the acyl chloride with hydrazine hydrate to yield 4-Bromo-3-methyl-benzoic Acid Hydrazide.

This method is widely used due to its simplicity and high yield. However, alternative synthetic strategies, such as microwave-assisted synthesis and catalytic methods, have also been explored to improve efficiency and reduce reaction times.

Biological Activity and Applications

4-Bromo-3-methyl-benzoic Acid Hydrazide has been studied for its potential biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. Recent research has highlighted its ability to inhibit specific enzymes and pathways involved in disease processes.

In one study published in the Journal of Medicinal Chemistry, researchers investigated the anti-inflammatory effects of 4-Bromo-3-methyl-benzoic Acid Hydrazide. The compound was found to effectively inhibit cyclooxygenase (COX) enzymes, which are key mediators of inflammation. This finding suggests that 4-Bromo-3-methyl-benzoic Acid Hydrazide could be developed into a novel anti-inflammatory drug with fewer side effects compared to existing COX inhibitors.

Another area of interest is the antimicrobial activity of 4-Bromo-3-methyl-benzoic Acid Hydrazide. Studies have shown that it exhibits potent activity against a range of bacteria, including both Gram-positive and Gram-negative strains. This property makes it a promising candidate for developing new antibiotics to combat multidrug-resistant pathogens.

In addition to its direct biological activities, 4-Bromo-3-methyl-benzoic Acid Hydrazide has been used as a building block in the synthesis of more complex molecules with enhanced therapeutic potential. For example, researchers have utilized this compound as a starting material for the preparation of novel antitumor agents that target specific signaling pathways in cancer cells.

Clinical Trials and Future Prospects

The promising preclinical results obtained with 4-Bromo-3-methyl-benzoic Acid Hydrazide have led to increased interest in its clinical evaluation. Several pharmaceutical companies are currently investigating this compound for various therapeutic applications.

In early-stage clinical trials, preliminary data suggest that derivatives of 4-Bromo-3-methyl-benzoic Acid Hydrazide exhibit favorable pharmacokinetic profiles and low toxicity levels. These findings are encouraging and warrant further investigation in larger clinical trials to assess their efficacy and safety in human subjects.

The future prospects for 4-Bromo-3-methyl-benzoic Acid Hydrazide are promising. Ongoing research aims to optimize its chemical structure to enhance its biological activity while minimizing potential side effects. Additionally, efforts are being made to develop more efficient synthetic routes to scale up production for commercial use.

Safety Considerations

Safety is a critical aspect when handling any chemical compound. While no specific safety concerns have been reported for 4-Bromo-3-methyl-benzoic Acid Hydrazide, it is important to follow standard laboratory safety protocols when working with this compound. Proper personal protective equipment (PPE), such as gloves and goggles, should be worn at all times. Additionally, appropriate ventilation should be maintained to prevent inhalation of any volatile compounds.

In conclusion, 4-Bromo-3-methyl-benzoic Acid Hydrazide (CAS No. 148672-43-9) is a multifaceted organic compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for developing novel therapeutic agents. As research continues to advance, it is likely that new applications for this compound will emerge, further solidifying its importance in the field.

• 39115-96-3(3-Bromobenzohydrazide)
• 170229-98-8(4-Bromo-3-methylbenzamide)
• 5526-50-1(4H-1-Benzopyran-4-one,3-[[4-(dimethylamino)phenyl]amino]-, hydrochloride (1:1))
• 864825-81-0(4-Bromo-3,5-dimethylbenzamide)
• 6781-60-8(Benzoic acid, 4-bromo-, 2-benzoylhydrazide)
• 29418-67-5(2-Bromobenzhydrazide)
• 50796-71-9(Benzoic acid, 2-bromo-,2-(2-bromobenzoyl)hydrazide)
• 5933-32-4(4-Bromobenzohydrazide)
• 108485-07-0(3-Bromo-2-methylbenzhydrazide)
• 84196-25-8(Benzoicacid, 3-bromo-, 2-(3-bromobenzoyl)hydrazide)